Shanghai Haoyuan Chemexpress Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Haoyuan Chemexpress has a total shareholder equity of CN¥2.6B and total debt of CN¥874.8M, which brings its debt-to-equity ratio to 33.1%. Its total assets and total liabilities are CN¥4.4B and CN¥1.7B respectively. Shanghai Haoyuan Chemexpress's EBIT is CN¥120.8M making its interest coverage ratio 3.6. It has cash and short-term investments of CN¥442.2M.
Key information
33.1%
Debt to equity ratio
CN¥874.76m
Debt
Interest coverage ratio | 3.6x |
Cash | CN¥442.23m |
Equity | CN¥2.64b |
Total liabilities | CN¥1.73b |
Total assets | CN¥4.37b |
Recent financial health updates
Recent updates
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) 25% Jump Shows Its Popularity With Investors
Sep 19Investors Appear Satisfied With Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Prospects
Jul 13Shanghai Haoyuan Chemexpress (SHSE:688131) Has A Somewhat Strained Balance Sheet
Jun 13Earnings Troubles May Signal Larger Issues for Shanghai Haoyuan Chemexpress (SHSE:688131) Shareholders
May 06After Leaping 27% Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE:688131) Shares Are Not Flying Under The Radar
Mar 20Financial Position Analysis
Short Term Liabilities: 688131's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥1.1B).
Long Term Liabilities: 688131's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥592.8M).
Debt to Equity History and Analysis
Debt Level: 688131's net debt to equity ratio (16.4%) is considered satisfactory.
Reducing Debt: 688131's debt to equity ratio has increased from 10.8% to 33.1% over the past 5 years.
Debt Coverage: 688131's debt is well covered by operating cash flow (23.8%).
Interest Coverage: 688131's interest payments on its debt are well covered by EBIT (3.6x coverage).